Cavernous hemangioma of the heart in a 37‑year‑old male visualized by multislice computed tomography (MSCT) (RCD code: VI‑1B.4)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2013, Vol 1, Issue 5
Abstract
A 37‑year‑old male with a 6‑month history of atypical nonexertional chest pain and markedly limited exercise capacity was referred for evaluation to our department. He had no previous medical history. There were no pathology in physical examination and laboratory tests. Standard ECG revealed inverse T‑waves in leads I and aVL, and 1st degree atrio‑ventricular block. Chest X‑ray demonstrated a tumor‑like structure on the left cardiac contour. Echocardiography revealed a large echolucent tumor adjacent to the lateral wall of the left ventricle. CT chest topogram was consistent with a large oval tumor on the left demarcation of the heart. Contrast‑enhanced coronary study showed a cystic tumor (75x80x80mm) located in the epicardium of the left ventricle and separated from the myocardium. The mid portion of the left anterior descending coronary artery (LAD) was located well within the tumor. Coronary angiography showed no coronary artery disease but significant modeling of a large portion of LAD on the tumor mass. Surgical resection of the mass was performed. Histopathologic examination revealed cavernous hemangioma, a rare primary heart tumor. The patient was discharged in good condition and was found symptom‑free 6 months later. JRCD 2013; 1 (5): 14–16
Authors and Affiliations
Małgorzata Konieczyńska, Katarzyna Stopyra-Pach, Robert Banyś
Keywords
Related Articles
- EP ID EP248123
- DOI 10.20418/jrcd.vol1no5.39
- Views 89
- Downloads 0
Therapy with sildenafil in a patient with pulmonary hypertension associated with end‑stage left ventricular failure (RCD code: II‑1B.1)
In the last decade the great progress was made in the therapy of pulmonary arterial hypertension (PAH). Unfortunately, there is still lack of evidence-based data how to manage with pulmonary hypertension due to left hear...
Biventricular cardiomyopathy improvement by shifting therapy from agalsidase alfa to agalsidase beta in Anderson‐Fabry Disease
Treatment of Fabry disease has improved since the introduction of enzyme replacement therapy (ERT). Two preparations of the recom‐ binant enzyme α‐galactosidase A are available: agalsidase alfa and agalsidase beta. We ai...
Classification of Rare Cardiovascular Diseases (RCD Classification), Krakow 2013
Almost every day brings new reports of a “rare” (“orphan”) disease – a disease that requires multidisciplinary knowledge and particular caution in making diagnostic and therapeutic decisions.The Classification of Rare Ca...
Case report on aortic valve replacement in adult woman with systemic mastocytosis (RCD code: VIII)
We present a case of a 50 year-old woman who was referred to our department with severe symptomatic aortic stenosis and systemic mastocytosis. Conventional mechanical aortic valve replacement was performed successfully w...
Superior vena cava syndrome associated with implantable cardiac devices procedures
INTRODUCTION: Superior vena cava (SVC) syndrome is a rare clinical disorder associated with obstructing venous outflow through the SVC. Although the most common cause is mediastinal tumors, the growing number of impla...